9,894 Shares in Agilent Technologies, Inc. $A Purchased by Arjuna Capital

Arjuna Capital purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 9,894 shares of the medical research company’s stock, valued at approximately $1,346,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Brighton Jones LLC boosted its position in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares during the period. Jones Financial Companies Lllp boosted its stake in shares of Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after purchasing an additional 769 shares during the period. Geneos Wealth Management Inc. boosted its stake in shares of Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after purchasing an additional 212 shares during the period. Acadian Asset Management LLC boosted its stake in shares of Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after purchasing an additional 758 shares during the period. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies during the second quarter valued at $273,000.

Analysts Set New Price Targets

A number of analysts recently issued reports on A shares. TD Cowen lowered their price target on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. UBS Group lowered their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Barclays lowered their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Finally, Wells Fargo & Company lowered their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $163.71.

Agilent Technologies Stock Performance

A stock opened at $111.69 on Friday. The firm has a market cap of $31.56 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 2.38 and a beta of 1.22. The firm has a 50-day simple moving average of $115.06 and a two-hundred day simple moving average of $130.68. Agilent Technologies, Inc. has a one year low of $107.07 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). The firm had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.